May 25, 2021
By: Rounak Jain
Credit: BCCL
It has partnered with Roche India to launch COVID-19 antibody cocktail (Casirivimab and Imdevimab) in India priced at ₹59,750 per dose for high-risk patients.
Credit: Cipla
It has launched Favipiravir antiviral drug for patients with mild to moderate COVID-19 infection.
Credit: Bal Pharma
The company will declare its March 2021 quarter results today.
Credit: Laxmi Organic
Lux, Laxmi Organic, Emami, Bajaj Electricals, Astrazeneca Pharma India, Bayer Cropscience, Computer Age Management Services, Gati, Ramco Systems, Johnson Controls-Hitachi Air Conditioning India, Stove Kraft, Transport Corporation of India, VIP Industries.
Credit: Pixabay
Clarios to sell 17.1 million shares of the company for $174 million, with the floor price fixed at ₹746 per share.
Credit: Amara Raja Batteries
Its March 2021 quarter net profit jumped by 36 percent to ₹480 crore while revenue increased by 18 percent to ₹4,394 crore.
Credit: Grasim Industries
Its March 2021 quarter net profit fell by 2 percent to 213 crore while revenue jumped by 8 percent to ₹718 crore.
Credit: Mahanagar Gas
It said that it has formed a COVID-19 related stress resolution mechanism in line with the RBI’s recent announcement.
Credit: SBI Cards
It has announced a final dividend of ₹4 per equity share.
Credit: JK Paper
It has commenced manufacturing at its Vatva facility near Ahmedabad from May 24.
Credit: GMM Pfaudler